Ranking the contributing risk factors in venous thrombosis in terms of therapeutic potential: Virchow's triad revisited

Journal of Obstetrics and Gynaecology Research

Volumn 32, Issue 2, 2006, Pages 216-223

  Kiyomura, Masaki ^a   Katayama, Tomihiro ^a   Kusanagi, Yasuki ^a   Ito, Masaharu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelial damage; Microcirculation; Platelet behavior; Thrombosis; Virchow's triad

Indexed keywords

ERYTHROPOIETIN; HUMORAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CARDIOVASCULAR RISK; CELL ADHESION; CELL ISOLATION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM LESION; EXAMINATION; FLUORESCENCE MICROSCOPY; HEMOCONCENTRATION; INJECTION; MALE; MESENTERY BLOOD FLOW; NONHUMAN; PATHOGENESIS; RAT; THROMBOCYTE; VEIN THROMBOSIS; VENOUS PRESSURE; VENOUS STASIS; VENULE;

ANIMALS; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; ERYTHROCYTES; HEMORHEOLOGY; MALE; PLATELET ADHESIVENESS; RATS; RATS, WISTAR; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VENOUS THROMBOSIS; VENULES;

EID: 33645082689     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2006.00374.x     Document Type: Article

References (38)

1. Virchow R Gesammalte Abhandlungen Zur Wissenschaftlichen Medtzin Frankfurt Medinger Sohn 1856 219 732
2. Resnick N Gimbrone MA Jr. Hemodynamic forces are complex regulators of endothelial gene expression FASEB J 1995 9 874 882
3. Wannamethee G Perry IJ Shaper AG Haematocrit, hypertension and risk of stroke J Intern Med 1994 235 163 168
4. Bergqvist D Benoni G Bjorgell O et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement N Engl J Med 1996 335 696 700
5. Curwen KD Gimbrone MA Handin RI In vitro studies of thromboresistance: The role of prostacyclin (PGI2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells Lab Invest 1980 42 366 374
6. Ruggeri ZM Mechanisms initiating platelet thrombus formation Thromb Haemost 1997 78 611 616
7. Katayama T Ikeda Y Handa M et al. Immunoneutralization of glycoprotein Ibalpha attenuates endotoxin-induced interactions of platelets and leukocytes with rat venular endothelium in vivo Circ Res 2000 86 1031 1037
8. Frisbie JH An animal model for venous thrombosis and spontaneous pulmonary embolism Spinal Cord 2005 43 635 639
9. Herbert JM Bernat A Maffrand JP Importance of platelets in experimental venous thrombosis in the rat Blood 1992 80 2281 2286
10. Weber M Gerdsen F Gutensohn K et al. Enhanced platelet aggregation with TRAP-6 and collagen in platelet aggregometry in patients with venous thromboembolism Thromb Res 2002 107 325 328
11. Wu KK Matijevic-Aleksic N Molecular aspects of thrombosis and antithrombotic drugs Crit Rev Clin Lab Sci 2005 42 249 277
12. Ebina Y Yamada H Kato EH et al. Thromboprophylaxis with low molecular weight heparin in thrombophilia-complicated pregnancy J Obstet Gynaecol Res 2002 28 251 257
13. Sekiyama K Itoh H Sagawa N et al. Successful management of a pregnant woman with heterozygous protein C deficiency using activated protein C concentrate J Obstet Gynaecol Res 2003 29 412 415
14. Tanaka H Umekawa T Kikukawa T Nakamura M Toyoda N Venous thromboembolic diseases associated with uterine myomas diagnosed before hysterectomy: A report of two cases J Obstet Gynaecol Res 2002 28 300 303
15. Morisaki H Katayama T Kotake Y et al. Roles of carbon monoxide in leukocyte and platelet dynamics in rat mesenteric during sevoflurane anesthesia Anesthesiology 2001 95 192 199
16. Katayama T Ikeda Y Handa M et al. Immunoneutralization of glycoprotein Ib alpha attenuates endotoxin-induced interactions of platelets and leukocytes with rat venular endothelium in vivo Circ Res 2000 86 1031 1037
17. Morisaki H Katayama T Kotake Y et al. Carbon monoxide modulates endotoxin-induced microvascular leukocyte adhesion through platelet-dependent mechanisms Anesthesiology 2002 97 701 709
18. Katayama T Kusanagi Y Kiyomura M Ochi H Ito M Leukocyte behavior and permeability in the rat mesenteric microcirculation following induction of ovulation Hum Reprod 2003 18 1179 1184
19. Heilmann L Siekmann U Schmid-Schonbein H Ludwig H Hemoconcentration and pre-eclampsia Arch Gynecol 1981 231 7 21
20. Tefferi A Solberg LA Silverstein MN A clinical update in polycythemia vera and essential thrombocythemia Am J Med 2000 109 141 149
21. Perloff JK Marelli AJ Miner PD Risk of stroke in adults with cyanotic congenital heart disease Circulation 1993 87 1954 1959
22. Pearson TC Wetherley-Mein G Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia Lancet 1978 2 1219 1222
23. Shibata J Hasegawa J Siemens HJ et al. Hemostasis and coagulation at a hematocrit level of 0.85: Functional consequences of erythrocytosis Blood 2003 101 4416 4422
24. Villeval JL Metcalf D Johnson GR Fatal polycythemia induced in mice by dysregulated erythropoietin production by hematopoietic cells Leukemia 1992 6 107 115
25. Clarke-Pearson DL Venous thromboembolic disease in pregnancy In Quilligan EJ Zuspan FP (eds) Current Therapy in Obstetrics and Gynecology 5th edn Philadelphia WB Saunders 2000 231 248
26. Ginsberg JS Brill-Edwards P Burrows RF et al. Venous thrombosis during pregnancy: Leg and trimester of presentation Thromb Haemost 1992 67 519 520
27. Stewart GJ Ritchie WG Lynch PR Venous endothelial damage produced by massive sticking and emigration of leukocytes Am J Pathol 1974 74 507 532
28. Kubes P Ischemia-reperfusion in feline small intestine: A role for nitric oxide Am J Physiol 1993 264 G143 G149
29. Letsky E Swiet M Maternal hemostasis: Coagulation problems of pregnancy In Loscalzo J Schafer A (eds) Thrombosis and Hemorrhage Boston Blackwell Scientific 1994 965 998
30. Cines DB Pollak ES Buck CA et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders Blood 1998 91 3527 3561
31. Downing LJ Wakefield TW Strieter RM et al. Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis J Vasc Surg 1997 25 816 828
32. Ridker PM Buring JE Rifai N Soluble P-selectin and the risk of future cardiovascular events Circulation 2001 103 491 495
33. Gonzalez-Juanatey C Testa A Garcia-Castelo A et al. Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody Arthritis Rheum 2004 51 447 450
34. Gotsch U Jager U Dominis M Vestweber D Expression of P-selectin on endothelial cells is upregulated by LPS and TNF-alpha in vivo Cell Adhes Commun 1994 2 7 14
35. Hogye M Mandi Y Csanady M Sepp R Buzas K Comparison of circulating levels of interleukin-6 and tumor necrosis factor-alpha in hypertrophic cardiomyopathy and in idiopathic dilated cardiomyopathy Am J Cardiol 2004 94 249 251
36. Matsubara K Abe E Ochi H Kusanagi Y Ito M Changes in serum concentrations of tumor necrosis factor alpha and adhesion molecules in normal pregnant women and those with pregnancy-induced hypertension J Obstet Gynaecol Res 2003 December 29 422 426
37. Cambien B Bergmeier W Saffaripour S Mitchell HA Wagner DD Antithrombotic activity of TNF-alpha J Clin Invest 2003 112 1589 1596
38. Heemskerk JW Bevers EM Lindhout T Platelet activation and blood coagulation Thromb Haemost 2002 88 186 193